Niels Svenstrup
Corporate Officer/Principal en PEPGEN INC. .
Fortuna: - $ al 30/04/2024
Cargos activos de Niels Svenstrup
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PEPGEN INC. | Corporate Officer/Principal | 01/04/2021 | - |
Historial de carrera de Niels Svenstrup
Antiguos cargos conocidos de Niels Svenstrup.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cydan II, Inc.
Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/07/2017 | 01/04/2021 |
ASCENDIS PHARMA A/S | Corporate Officer/Principal | 01/11/2015 | 01/07/2017 |
H. LUNDBECK A/S | Corporate Officer/Principal | 01/05/2008 | 01/11/2015 |
Formación de Niels Svenstrup.
University of Southern Denmark | Doctorate Degree |
Estadísticas
Internacional
Dinamarca | 4 |
Estados Unidos | 3 |
Operativa
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
PEPGEN INC. | Health Technology |
ASCENDIS PHARMA A/S | Health Technology |
H. LUNDBECK A/S | Health Technology |
Empresas privadas | 1 |
---|---|
Cydan II, Inc.
Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Niels Svenstrup
- Experiencia